Opinion
Caution over AstraZeneca comes at a cost
The comparative health costs say that restricting the use of the AstraZeneca vaccine is not worth the risk to herd immunity.
Sam LovickContributorCould we be about to see the federal government turn a silk purse into a sow’s ear? Their latest pronouncement on vaccination could do just that.
The government, with the assistance of the states and the acquiescence of a patient and compliant population, has managed to stem the worst effects of the global pandemic. They have done this by, in essence, closing the borders, injecting vast amounts of liquidity into the economy by subsidising jobs, and riding the resurgence of commodity prices. In large part, these have offset the disastrous effects of the pandemic on education and tourism.
Subscribe to gift this article
Gift 5 articles to anyone you choose each month when you subscribe.
Subscribe nowAlready a subscriber?
Introducing your Newsfeed
Follow the topics, people and companies that matter to you.
Find out moreRead More
Latest In Health & education
Fetching latest articles